Bivalirudin is a synthetic 20-residue peptide that functions as a potent direct thrombin inhibitor, used clinically to prevent clot formation during percutaneous coronary intervention. As an anticoagulant,… Read more
![Chemical structure of [Des-Glu13]-Bivalirudin](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1107611-94-8-Des-Glu13-Bivalirudin.png&w=3840&q=75)
![Chemical structure of Bivalirudin Impurity ([Beta-Asp9]-Bivalirudin)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FBivalirudin-Impurity-Beta-Asp9-Bivalirudin.png&w=3840&q=75)











Bivalirudin is a synthetic 20-residue peptide that functions as a potent direct thrombin inhibitor, used clinically to prevent clot formation during percutaneous coronary intervention. As an anticoagulant, it reversibly binds to both free and clot-bound thrombin, offering an alternative to indirect inhibitors like heparin. This category provides essential reference standards for the Bivalirudin API, alongside its related pharmacopeial and non-pharmacopeial impurities, such as Asp9 and various Des-Glu variants. Pharmaceutical laboratories utilize these materials for comprehensive impurity profiling, method validation, and quality control of therapeutic formulations. Additionally, the collection includes stable isotope-labelled compounds, which are critical for high-precision quantification in bioanalytical studies and advanced analytical testing, ensuring accurate assessment of drug purity and stability throughout the manufacturing process.